AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Nathan, RA Nayak, AS Graft, DF Lawrence, M Picone, FJ Ahmed, T Wolfe, J Vanderwalker, ML Nolop, KB Harrison, JE
Citation: Ra. Nathan et al., Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate, ANN ALLER A, 86(2), 2001, pp. 203-210

Authors: Noonan, M Karpel, JP Bensch, GW Ramsdell, JW Webb, DR Nolop, KB Lutsky, BN
Citation: M. Noonan et al., Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler, ANN ALLER A, 86(1), 2001, pp. 36-43

Authors: Nayak, AS Banov, C Corren, J Feinstein, BK Floreani, A Friedman, BF Goldsobel, A Gottschlich, GM Hannaway, PJ Lampl, KL Lapidus, RJ Lawrence, M Lumry, W Munk, Z Pearlman, D Scardella, AT Schenkel, EJ Segal, AT Segall, N Silverman, B Shneyer, L Nolop, KB Harrison, JE
Citation: As. Nayak et al., Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma, ANN ALLER A, 84(4), 2000, pp. 417-424

Authors: Bousquet, J D'Urzo, A Hebert, J Barraza, CH Boulet, LP Suarez-Chacon, R Harnest, U Lundback, B Morales, GM Nieminen, MM Nolop, KB Visser, S Lutsky, BN
Citation: J. Bousquet et al., Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler (R), EUR RESP J, 16(5), 2000, pp. 808-816

Authors: Fish, JE Karpel, JP Craig, TJ Bensch, GW Noonan, M Webb, DR Silverman, B Schenkel, EJ Rooklin, AR Ramsdell, JW Nathan, R Leflein, JG Grossman, J Graft, DF Gower, RG Garay, SM Frigas, E DeGraff, AC Bronsky, EA Bernstein, DI Berger, W Shneyer, L Nolop, KB Harrison, JE
Citation: Je. Fish et al., Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related duality of life in patients with severe persistent asthma, J ALLERG CL, 106(5), 2000, pp. 852-860

Authors: Schenkel, EJ Skoner, DP Bronsky, EA Miller, SD Pearlman, DS Rooklin, A Rosen, JP Ruff, ME Vandewalker, ML Wanderer, A Damaraju, CV Nolop, KB Mesarina-Wicki, B
Citation: Ej. Schenkel et al., Absence of growth retardation in children with perennial allergic rhinitisafter one year of treatment with mometasone furoate aqueous nasal spray, PEDIATRICS, 105(2), 2000, pp. E221-E227

Authors: Bernstein, DI Berkowitz, RB Chervinsky, P Dvorin, DJ Finn, A Gross, GN Karetzky, M Kemp, JP Laforce, C Lumry, W Mendelson, LM Nelson, H Pearlman, D Rachelefsky, G Ratner, P Repsher, L Segal, AT Selner, JC Settipane, GA Wanderer, A Cuss, FM Nolop, KB Harrison, JE
Citation: Di. Bernstein et al., Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler, RESP MED, 93(9), 1999, pp. 603-612

Authors: Berkowitz, RB Bernstein, DI LaForce, C Pedinoff, AJ Rooklin, AR Damaraju, CRV Mesarina-Wicki, B Nolop, KB
Citation: Rb. Berkowitz et al., Onset of action of mometasone furoate nasal spray (NASONEX (R)) in seasonal allergic rhinitis, ALLERGY, 54(1), 1999, pp. 64-69

Authors: Meltzer, EO Berger, WE Berkowitz, RB Bronsky, EA Dvorin, DJ Finn, AF Galant, SP Grossman, J Hampel, FC Ratner, PH Ruff, ME Schenkel, EJ Segal, AT Segall, N Stewart, GE Tripathy, I Skoner, DP Anolik, R Dockhorn, RJ van Bavel, J Mesarina-Wicki, B Nolop, KB
Citation: Eo. Meltzer et al., A dose-ranging study of mometasone furoate aqueous nasal spray in childrenwith seasonal allergic rhinitis, J ALLERG CL, 104(1), 1999, pp. 107-114

Authors: Frieri, M Therattil, J Chavarria, V Cosachov, J Kumar, NS Wang, SF Sansone, G Etzel, J Dellevecchia, D Zitt, M Mesarina-Wicki, B Nolop, KB
Citation: M. Frieri et al., Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis, ANN ALLER A, 81(5), 1998, pp. 431-437
Risultati: 1-10 |